Suppr超能文献

择期脾次全切除术。33例患者的适应证及结果

Elective subtotal splenectomy. Indications and results in 33 patients.

作者信息

Guzzetta P C, Ruley E J, Merrick H F, Verderese C, Barton N

机构信息

Department of Surgery, Children's Hospital National Medical Center, Washington, D.C. 20010.

出版信息

Ann Surg. 1990 Jan;211(1):34-42. doi: 10.1097/00000658-199001000-00006.

Abstract

Elective subtotal splenectomy was performed in 33 patients (30 children and 3 adults) between 1981 and 1989. Indications for the procedure were (1) prevention of azathioprine-induced neutropenia (n = 20); (2) Type I Gaucher disease (n = 9); and (3) cholesteryl ester storage disease, chronic myelogenous leukemia, thalassemia major, and splenic cyst in one patient each. There were no operative deaths, no reoperations for bleeding, and 30 of 33 (91%) patients had a functioning splenic remnant documented by a postoperative radionuclide spleen scan. One patient developed neutropenia without evidence of viral infection that required temporary cessation of azathioprine and the patient with thalassemia major had only transient improvement in transfusion requirements. All other patients (94%) had control of the underlying condition for which the operation was performed. We conclude that subtotal splenectomy is a safe, effective therapy for a variety of nontraumatic conditions.

摘要

1981年至1989年间,对33例患者(30名儿童和3名成人)实施了择期脾次全切除术。该手术的适应证为:(1)预防硫唑嘌呤诱导的中性粒细胞减少症(n = 20);(2)Ⅰ型戈谢病(n = 9);(3)胆固醇酯贮积病、慢性粒细胞白血病、重型地中海贫血和脾囊肿各1例。无手术死亡病例,无因出血而再次手术的情况,33例患者中有30例(91%)术后放射性核素脾扫描显示脾残余功能良好。1例患者出现中性粒细胞减少症,无病毒感染证据,需要暂时停用硫唑嘌呤,重型地中海贫血患者的输血需求仅得到短暂改善。所有其他患者(94%)的基础疾病得到了控制。我们得出结论,脾次全切除术是治疗多种非创伤性疾病的一种安全、有效的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da98/1357890/309221de20b3/annsurg00167-0043-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验